Organon & (OGN)

Search documents
Organon & Co. (OGN) CEO Kevin Ali At 4th Annual Evercore ISI HealthCONx Conference (Transcript)
2021-12-01 21:46
Organon & Co. (NYSE:OGN) 4th Annual Evercore ISI HealthCONx Conference December 1, 2021 1:50 PM ET Company Participants Kevin Ali - CEO Matthew Walsh - CFO Conference Call Participants Umer Raffat - Evercore Eric Musonza - Evercore Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly e ...
Organon & (OGN) - 2021 Q3 - Quarterly Report
2021-11-12 21:52
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________ Form 10-Q ________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File No. 001-40235 Organon & Co. (Exact name of registrant as specified in its charter) ...
Organon & (OGN) - 2021 Q3 - Earnings Call Transcript
2021-11-11 18:43
Organon & Co. (NYSE:OGN) Q3 2021 Results Conference Call November 11, 2021 8:30 AM ET Company Participants Kevin Ali – Chief Executive Officer Matt Walsh – Chief Financial Officer Jennifer Halchak – Vice President, Investor Relations Conference Call Participants Chris Schott – JP Morgan Navann Ty – Citi Umer Raffat – Evercore Steven Scala – Cowen Greg Fraser – Truist Securities Ashville with Bank – America Charlie Yang – Morgan Stanley David Amsellem – Piper Jaffray Operator Ladies and gentlemen, thank you ...
Organon & (OGN) - 2021 Q3 - Earnings Call Presentation
2021-11-11 18:03
Organon Q3 2021 Earnings · · · ORGANON™ Disclaimer statement This text should be viewed in conjunction with Organon's Q3 2021 earnings call Safe Harbor for Forward-Looking Statements Except for the historical information herein, this presentation of Organon & Co. (the "company") includes "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including, but not limited to, statements about management's expectations about Org ...
Organon & (OGN) - 2021 Q2 - Quarterly Report
2021-08-16 12:20
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________ Form 10-Q ________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File No. 001-40235 Organon & Co. (Exact name of registrant as specified in its charter) Delawar ...
Organon & (OGN) - 2021 Q2 - Earnings Call Transcript
2021-08-12 18:32
Organon & Co (NYSE:OGN) Q2 2021 Earnings Conference Call August 12, 2021 8:30 AM ET Company Participants Jennifer Halchak – Vice President of Investor Relations Kevin Ali – Chief Executive Officer Matt Walsh – Chief Financial Officer Conference Call Participants Terence Flynn – Goldman Sachs Navann Ty – Citi Greg Fraser – Truist Securities Charlie Yang – Morgan Stanley Umer Raffat – Evercore ISI Steve Scala – Cowen Operator Good day and thank you for standing by. Welcome to the Organon's Second Quarter Earn ...
Organon & (OGN) - 2021 Q2 - Earnings Call Presentation
2021-08-12 14:05
Organon Q2 2021 Earnings ·炉 ORGANON Disclaimer statement 2 This text should be viewed in conjunction with Organon's Q2 2021 earnings call Safe Harbor for Forward-Looking Statements Exc p f r h h s r c l f rm h r h s pr s f Org & . ( h "c mp y") cl s "f rw r -looking statem s" w h h meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including, but not limited to, statements m g m 's xp c s Org 's f r f c l p rf rm c pr sp c s. F rw r -looking statements may be ...
Organon & (OGN) - 2021 Q1 - Quarterly Report
2021-06-21 12:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________ Form 10-Q ________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File No. 001-40235 Organon & Co. (Exact name of registrant as specified in its charter) Del ...